Do DSMBs Need AI Expertise?
Rethinking oversight as clinical trials become more data-driven and algorithm-informed As artificial intelligence (AI) becomes more embedded in clinical trial
Rethinking oversight as clinical trials become more data-driven and algorithm-informed As artificial intelligence (AI) becomes more embedded in clinical trial
Heading to the Advarra Innovation Summit in London? Share the news and encourage your peers and partners to join you!
MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping shape how teams show up for
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the
Evan Sander knows firsthand that clinical research is never just about processes or paperwork—it’s about people. As associate director of
Federal Public Policy Briefing: Understanding 21 CFR 50.54: When FDA-Regulated Pediatric Research Requires Federal Review Research involving children that poses
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when that complexity creates friction in
Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular endothelial growth factor (anti-VEGF), have
Why we exist Oncology research is moving quickly, and study teams face mounting complexity: novel modalities, new data tools, shifting
For Jani Viox, clinical research is more than a profession—it’s personal. As a senior coordinator of client services at Advarra, Jani
Clinical trial study design forms the foundation of trial success. The decisions teams make at the design stage shape how